Healthcare provider profile · identity verified

Geetha Ganesan, M.D.

Internal Medicine · WAUWATOSA, WI · NPI 1003849407

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	613	181
Atorvastatin Calcium	Atorvastatin Calcium	552	149
Levothyroxine Sodium	Levothyroxine Sodium	524	124
Omeprazole	Omeprazole	511	139
Rosuvastatin Calcium	Rosuvastatin Calcium	429	112
Simvastatin	Simvastatin	403	105
Metoprolol Succinate	Metoprolol Succinate	354	96
Gabapentin	Gabapentin	304	112
Losartan Potassium	Losartan Potassium	293	89
Albuterol Sulfate Hfa	Albuterol Sulfate	278	114
Lisinopril	Lisinopril	265	71
Furosemide	Furosemide	256	73
Metformin Hcl	Metformin Hcl	228	53
Metformin Hcl Er	Metformin Hcl	220	53
Carvedilol	Carvedilol	218	58
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	218	51
Pantoprazole Sodium	Pantoprazole Sodium	192	50
Fluticasone Propionate	Fluticasone Propionate	173	60
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	171	48
Potassium Chloride	Potassium Chloride	169	44
Escitalopram Oxalate	Escitalopram Oxalate	168	43
Hydrochlorothiazide	Hydrochlorothiazide	168	46
Montelukast Sodium	Montelukast Sodium	166	43
Trazodone Hcl	Trazodone Hcl	150	47
Allopurinol	Allopurinol	149	37
Metoprolol Tartrate	Metoprolol Tartrate	146	40
Fluoxetine Hcl	Fluoxetine Hcl	137	33
Glimepiride	Glimepiride	136	31
Mirtazapine	Mirtazapine	126	30
Alendronate Sodium	Alendronate Sodium	121	35
Tamsulosin Hcl	Tamsulosin Hcl	115	29
Jardiance	Empagliflozin	108	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	107	29
Vitamin D2	Ergocalciferol (Vitamin D2)	107	39
Azithromycin	Azithromycin	98	83
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	98	33
Bupropion Xl	Bupropion Hcl	84	23
Ezetimibe	Ezetimibe	81	22
Triamcinolone Acetonide	Triamcinolone Acetonide	79	42
Pravastatin Sodium	Pravastatin Sodium	78	23
Clopidogrel	Clopidogrel Bisulfate	74	16
Famotidine	Famotidine	74	22
Sertraline Hcl	Sertraline Hcl	74	16
Duloxetine Hcl	Duloxetine Hcl	72	23
Meloxicam	Meloxicam	68	27
Methylprednisolone	Methylprednisolone	60	58
Januvia	Sitagliptin Phosphate	57	16
Spironolactone	Spironolactone	57	15
Eliquis	Apixaban	56	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	56	25
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	55	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	53	44
Finasteride	Finasteride	51	suppressed
Warfarin Sodium	Warfarin Sodium	50	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	48	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	48	15
Doxazosin Mesylate	Doxazosin Mesylate	46	15
Meclizine Hcl	Meclizine Hcl	45	16
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Breo Ellipta	Fluticasone/Vilanterol	42	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	42	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	37
Ozempic	Semaglutide	39	suppressed
Prednisone	Prednisone	38	34
Symbicort	Budesonide/Formoterol Fumarate	38	suppressed
Valacyclovir	Valacyclovir Hcl	35	16
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Fenofibrate	Fenofibrate	33	suppressed
Atenolol	Atenolol	32	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	30	22
Fluconazole	Fluconazole	30	25
Glipizide Er	Glipizide	30	suppressed
Pregabalin	Pregabalin	30	16
Donepezil Hcl	Donepezil Hcl	28	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	28	suppressed
Propranolol Hcl Er	Propranolol Hcl	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Valsartan	Valsartan	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Telmisartan	Telmisartan	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Colchicine	Colchicine	23	11
Linzess	Linaclotide	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Folic Acid	Folic Acid	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	13
Clobetasol Propionate	Clobetasol Propionate	19	14
Farxiga	Dapagliflozin Propanediol	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Mupirocin	Mupirocin	19	14
Advair Diskus	Fluticasone Propion/Salmeterol	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	16
Irbesartan	Irbesartan	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Topiramate	Topiramate	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	13
Terazosin Hcl	Terazosin Hcl	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Humalog Kwikpen U-200	Insulin Lispro	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Nystatin	Nystatin	14	suppressed
Testosterone	Testosterone	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Metolazone	Metolazone	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Torsemide	Torsemide	12	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error